Composition Comprising Lactic Acid Bacteria Derived from Green Tea for Improving Liver Function
Summary
USPTO granted patent US12594310B2 to AMOREPACIFIC CORPORATION on April 7, 2026, covering a method for improving hepatic function using a composition derived from green tea-derived Lactiplantibacillus plantarum strain. The patent includes 6 claims and covers the strain, culture, lysate, and extracts thereof.
What changed
USPTO issued patent grant US12594310B2 to AMOREPACIFIC CORPORATION for a composition and method utilizing a green tea-derived Lactiplantibacillus plantarum strain to improve liver function. The patent claims cover the bacterial strain itself, cultures thereof, lysates, and various extracts from the strain or its culture. The filing date was May 8, 2023, with application number 18313465.
The grant provides AMOREPACIFIC CORPORATION with exclusive rights to the patented composition and method in the United States. Competitors in the functional food, dietary supplement, and pharmaceutical sectors must avoid infringing these claims when developing similar probiotic liver health products. Parties interested in licensing this technology or designing around the patent should review the full claim scope.
What to do next
- Monitor for updates
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Composition comprising lactic acid bacteria derived from green tea for improving liver function
Grant US12594310B2 Kind: B2 Apr 07, 2026
Assignee
AMOREPACIFIC CORPORATION
Inventors
Hyun Woo Jeong, Donghyun Cho, Wanki Kim, Jong Hwa Roh
Abstract
A method for improving hepatic function, including administering an effective amount of a composition including a green tea-derived Lactiplantibacillus plantarum strain; a culture of the strain; a lysate of the strain; an extract of the strain; an extract of the culture; or an extract of the lysate to a subject in need thereof is disclosed in the specification.
CPC Classifications
A61P 1/16 A61K 35/747 A61K 36/82
Filing Date
2023-05-08
Application No.
18313465
Claims
6
Related changes
Get daily alerts for USPTO Patent Grants - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.